造血干细胞移植受者及血液肿瘤患者的寨卡与基孔肯雅病毒感染
本研究为前瞻性协作研究,评估登革、基孔肯雅和寨卡病毒在造血干细胞移植受者及血液肿瘤患者中的患病率、发病率和死亡率。2016年2月至5月,26例符合病例定义(发热和皮疹)的患者中9例(34.6%)确诊登革(3例)、寨卡(4例)或基孔肯雅(2例)感染。登革和寨卡病例分别观察到 prolonged 病毒血症和尿病毒排出,血小板减少是最常见并发症,所有患者存活无后遗症。
要点
- 26例符合发热和皮疹病例定义的患者中9例(34.6%)确诊虫媒病毒感染。
- 登革和寨卡病例分别观察到 prolonged 病毒血症和尿病毒排出。
- 血小板减少是最常见并发症,1例移植前25天感染寨卡的患者出现植入延迟。
核心结论
- 在虫媒病毒地理扩张背景下,供者和受者筛查可能成为强制要求。
- 居住于非流行区的患者同样有风险,因这些病毒可通过血液及器官或组织移植传播。
研究设计与样本
- 前瞻性协作研究,评估登革、基孔肯雅和寨卡病毒在造血干细胞移植受者及血液肿瘤患者中的患病率、发病率和死亡率。
- 采用病例定义策略(发热和皮疹)触发诊断检查,通过血浆和尿液样本实时聚合酶链反应检测。
- 症状出现后7天和30天进行临床随访。
主要发现
- 2016年2月至5月,26例符合病例定义标准的患者中9例(34.6%)确诊登革(3例)、寨卡(4例)或基孔肯雅(2例)感染。
- 登革和寨卡病例分别观察到 prolonged 病毒血症和尿病毒排出。
- 血小板减少是最常见并发症。
- 1例在造血干细胞移植前25天感染寨卡的患者出现植入延迟。
- 所有患者存活无后遗症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aedes mosquitoes are well adapted in domestic environments and widespread in tropical regions. Since 2015, Brazil has been experiencing a triple epidemic of dengue (DENV), chikungunya (CHKV), and Zika (ZIKV) viruses. The last 2 viruses are likely following the path of DENV, which has been endemic in most parts of the country since the 1980s. Given this triple epidemic, we proposed a prospective and collaborative study to assess the prevalence, morbidity, and mortality of DENV, CHKV, and ZIKV infections in hematopoietic stem cell transplant (HSCT) recipients and oncohematological patients. A case definition strategy (fever and rash) was used to prompt diagnostic investigation of DENV, ZIKV, and CHKV, which was accomplished by real-time polymerase chain reaction with plasma and urine samples. Clinical follow-up was performed 7 and 30 days after symptom onset. We report here the first cases of ZIKV and CHKV infections diagnosed in this ongoing study. From February to May 2016, 9 of the 26 patients (34.6%) fulfilling case definition criteria were diagnosed with DENV (3 cases), ZIKV (4 cases), or CHKV (2 cases) infections. Prolonged viremia and viruria were observed in dengue and Zika fever cases, respectively. Thrombocytopenia was the most frequent complication. Delayed engraftment was noted in 1 patient who acquired ZIKV 25 days before HSCT. All patients survived without sequelae. With the geographic expansion of arboviruses, donor and recipient screening may become mandatory. Patients living in areas where these viruses are not endemic are also at risk, since these viruses can be transmitted by blood as well as organ or tissue transplantation.
引用
- Machado CM, Pereira BBS, Felix AC, et al. Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients. Blood Adv. 2017. PMID: 29296705. doi:10.1182/bloodadvances.2016003285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。